NCT05619367 2025-12-23A Compassionate Use (CU) Program of OdronextamabRegeneron PharmaceuticalsAvailable
NCT04400591 2025-12-11Nonconforming Lisocabtagene Maraleucel Expanded Access ProtocolJuno Therapeutics, a Subsidiary of CelgeneAvailable